DeepSyte™
Bill FeedAll repsScoreboardsPrimariesProAboutSign inGet started
DeepSyte™™

A nonpartisan civic accountability tool. We match federal legislation to your stated values — without partisan bias.

Learn

  • About
  • About the name
  • Methodology
  • Glossary

Legal

  • Privacy
  • Terms of Service
  • Refund Policy
  • Contact

Sources

Bill data from Congress.gov. Summaries from the Congressional Research Service where available.

Follow

  • Bluesky — @deepsyte.app
  • X — @deepsyteapp
All content is for informational purposes only. Always verify against primary sources.
Back to bill feed
118-s-5349Committee
Sign in to get alerts

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Read the record. Not the rhetoric.

See how your representatives voted on this bill.

DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.

Get started freeTake the values quiz

Alignment with your views

Sign in and take the values quiz to see how this bill lines up with what you've said.

Summary

AI-generated summary — verify against full text

This bill amends Medicare law to establish a pathway for prompt coverage of breakthrough medical devices. It creates a 4-year transitional coverage period during which breakthrough devices (those designated by the FDA as receiving priority review) would be covered by Medicare, provided they are used according to FDA-approved labeling and do not present undue risk. The bill requires the Secretary of Health and Human Services to issue final coverage determinations for these devices before the transitional period ends and appropriates $10 million annually through 2030 to implement the program.

Read full bill text

Values analysis

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.

Bill details

Congress
118
Bill type
s
Introduced
November 20, 2024
Sponsor
Not yet available
Last action
November 20, 2024— Read twice and referred to the Committee on Finance.

How your representatives voted

Sign in to see how your representatives voted on this bill.